DMs can be divided into several subtypes according to their different myositis-specific autoantibodies (MSAs), among which anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody defines a distinct phenotype of DMs, namely anti-MDA5 antibody-positive DM (MDA5+ DM). This evidence concerns the gene IFIH1 and myositis disease.